Ligand id: 1324

Name: afamelanotide

Structure and Physico-chemical Properties

2D Structure
Click here for structure editor
No information available.
Summary of Clinical Use
Afamelanotide is approved to prevent phototoxicity in adults with erythropoietic protoporphyria [2-3,5].
Mechanism Of Action and Pharmacodynamic Effects
Afamelanotide stimulates the production of eumelanin in the skin to provide protection against the phototoxic effects of exposure to sunlight in patients with erythropoietic protoporphyria.
External links